TABLE 3—
Anti-HBc at Follow-Up, Months |
||||||||
Patient | Age, Years | Gender | Anti-HBs Status at 12 Months (mIU/mL) | Vaccination Schedule | 6 | 12 | 18 | 24 |
1 | 53 | Male | < 10 | Standard | + | — | — | + |
2 | 54 | Male | < 10 | Standard | + | + | + | + |
3 | 43 | Male | < 10 | Standard | + | — | + | + |
4 | 54 | Female | < 10 | Standard | — | + | + | + |
5 | 41 | Male | < 10 | Standard | + | + | — | — |
6 | 52 | Male | ≥ 10 | Standard | — | + | + | + |
7 | 29 | Female | ≥ 10 | Standard | — | + | — | + |
8 | 28 | Male | < 10 | Standard | +a | — | — | + |
9 | 43 | Male | < 10 | Accelerated | + | + | — | — |
10 | 27 | Male | ≥ 10 | Accelerated | — | — | — | +a |
Note. HBc = hepatitis B core; HBs = hepatitis B; HBsAg = hepatitis B surface antigen; — = missing.
HBsAg positive.